<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>9cee43d4-f5bb-4174-b4c8-0aeb1f859b1f</id>
  <name>AHS OGR ADULT SUR Anti-Infective Agents - Major Gynecology and Gynecologic Oncology Preprocedure</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.EPIC ID</key>
        <value>&lt;p&gt;OSQ 179256&lt;/p&gt;</value>
      </item>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~9cee43d4-f5bb-4174-b4c8-0aeb1f859b1f~NAME~AHS OGR ADULT SUR Anti-Infective Agents - Major Gynecology and Gynecologic Oncology Preprocedure}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Refer to AHS Surgical Prophylaxis Recommendations for specific antibiotic recommendations based on surgery type, patient weight and allergies. &amp;nbsp;Antibiotics should be given within 60 minutes prior to incision. &amp;nbsp;For exceptions to this, see Table 1 of AHS Surgical Prophylaxis Recommendations.&lt;br&gt;&amp;nbsp;&lt;br&gt;If patient has ceFAZolin allergy or severe non-IgE mediated reaction to any β-lactam (see AHS Algorithm for β-lactam Allergy and Surgical Prophylaxis)&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;u&gt;AHS Surgical Prophylaxis Recommendations&lt;/u&gt;&lt;/strong&gt; (URL: https://ahsweb.ca/HEE/AHS_Recommended_Drug_Regimens_for_Surgical_Prophylaxis_in_Adult_Patients)&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;u&gt;AHS Algorithm for beta-lactam Allergy and Surgical Prophylaxis&lt;/u&gt;&lt;/strong&gt; (URL: https://ahsweb.ca/HEE/AHS_beta_lactam_Allergy_Surgical_Prophylaxis)&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ceFAZolin IV (add metroNIDAZOLE for procedures entering the rectum)&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ceFAZolin IV/IM; 2 g, intravenous, on call to surgical suite, to be given within 60 minutes prior to incision&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;ceFAZolin IV (add metroNIDAZOLE for procedures entering the rectum)&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;gentamicin + clindamycin IV - If patient has ceFAZolin allergy or severe non-IgE mediated reaction to any beta-lactam&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Anti-Infective Agents - Major Gynecology and Gynecologic Oncology">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="ceFAZolin IV (add metroNIDAZOLE for procedures entering the rectum)">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM CEFAZOLIN IM IV ORDERABLE [420006] Order" max="1" path="/items" name="ceFAZolin IV/IM; 2 g, intravenous, on call to surgical suite, to be given within 60 minutes prior to incision"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="646c8a3d-efb3-4d4e-889a-0b5b5b614ee8" concept_name="PHARM METRONIDAZOLE IV ORDERABLE [420507] Order" max="1" path="/items" name="metroNIDAZOLE IV; 500 mg, intravenous, on call to surgical suite, to be given within 60 minutes prior to incision"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="ab422ae1-d036-4c4a-9e40-7161b9c4e4ef" concept_name="AHS OGR ADULT SUR gentamicin and clindamycin IV Preprocedure" max="1" path="/items" name="gentamicin + clindamycin IV - If patient has ceFAZolin allergy or severe non-IgE mediated reaction to any beta-lactam"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>